MicroRNAs in Autoimmune Sjögren’s Syndrome

MicroRNAs (miRNAs), small non-coding RNAs, have been implicated in various diseases and cellular functions as microregulators of gene expression. Although the history of miRNA investigation in autoimmune Sjögren’s syndrome (SjS) is fairly short, a substantial amount of data has already been accumula...

Full description

Saved in:
Bibliographic Details
Main Authors: Seunghee Cha, Mahmoud Mona, Kyung Eun Lee, Dong Hee Kim, Kyudong Han
Format: Article
Language:English
Published: BioMed Central 2018-12-01
Series:Genomics & Informatics
Subjects:
Online Access:http://genominfo.org/upload/pdf/gi-2018-16-4-e19.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832569038001143808
author Seunghee Cha
Mahmoud Mona
Kyung Eun Lee
Dong Hee Kim
Kyudong Han
author_facet Seunghee Cha
Mahmoud Mona
Kyung Eun Lee
Dong Hee Kim
Kyudong Han
author_sort Seunghee Cha
collection DOAJ
description MicroRNAs (miRNAs), small non-coding RNAs, have been implicated in various diseases and cellular functions as microregulators of gene expression. Although the history of miRNA investigation in autoimmune Sjögren’s syndrome (SjS) is fairly short, a substantial amount of data has already been accumulated. These findings clearly indicate potential clinical implications of miRNAs, such as autoantigen expression and autoantibody production, viral miRNAs regulating the calcium signaling pathway, and aberrant immune cell regulation and cytokine production. Research endeavors in the field are currently underway to select disease-specific diagnostic and prognostic biomarkers by utilizing different types of tissues or biological specimens of SjS patients. Various techniques for miRNA analysis with different stringencies have been applied, with the most recent one being next-generation sequencing. This review compiles and highlights differentially-expressed miRNAs in various samples collected from SjS patients and their potential implications in the pathogenesis of SjS. To facilitate the development of miRNA-targeted personalized therapy in the future, we urge more follow-up studies that confirm these findings and elucidate the immunopathological roles of differentially-expressed miRNAs. Furthermore, improved diagnostic criteria for the disease itself will minimize sampling errors in patient recruitment, preventing the generation of inconsistent data.
format Article
id doaj-art-337d1eda4d52431e909a090658dd911a
institution Kabale University
issn 2234-0742
language English
publishDate 2018-12-01
publisher BioMed Central
record_format Article
series Genomics & Informatics
spelling doaj-art-337d1eda4d52431e909a090658dd911a2025-02-02T23:17:26ZengBioMed CentralGenomics & Informatics2234-07422018-12-0116410.5808/GI.2018.16.4.e19523MicroRNAs in Autoimmune Sjögren’s SyndromeSeunghee Cha0Mahmoud Mona1Kyung Eun Lee2Dong Hee Kim3Kyudong Han4 Department of Oral and Maxillofacial Diagnostic Sciences, College of Dentistry, University of Florida, Gainesville, FL 32610, USA Department of Oral and Maxillofacial Diagnostic Sciences, College of Dentistry, University of Florida, Gainesville, FL 32610, USA Department of Oral Medicine, School of Dentistry, Chonbuk National University, Jeonju 54896, Korea Department of Anesthesiology and Pain Management, College of Medicine, Dankook University, Cheonan 31116, Korea Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, KoreaMicroRNAs (miRNAs), small non-coding RNAs, have been implicated in various diseases and cellular functions as microregulators of gene expression. Although the history of miRNA investigation in autoimmune Sjögren’s syndrome (SjS) is fairly short, a substantial amount of data has already been accumulated. These findings clearly indicate potential clinical implications of miRNAs, such as autoantigen expression and autoantibody production, viral miRNAs regulating the calcium signaling pathway, and aberrant immune cell regulation and cytokine production. Research endeavors in the field are currently underway to select disease-specific diagnostic and prognostic biomarkers by utilizing different types of tissues or biological specimens of SjS patients. Various techniques for miRNA analysis with different stringencies have been applied, with the most recent one being next-generation sequencing. This review compiles and highlights differentially-expressed miRNAs in various samples collected from SjS patients and their potential implications in the pathogenesis of SjS. To facilitate the development of miRNA-targeted personalized therapy in the future, we urge more follow-up studies that confirm these findings and elucidate the immunopathological roles of differentially-expressed miRNAs. Furthermore, improved diagnostic criteria for the disease itself will minimize sampling errors in patient recruitment, preventing the generation of inconsistent data.http://genominfo.org/upload/pdf/gi-2018-16-4-e19.pdfautoantibodiesmicroRNAsSjögren’s syndromexerostomia
spellingShingle Seunghee Cha
Mahmoud Mona
Kyung Eun Lee
Dong Hee Kim
Kyudong Han
MicroRNAs in Autoimmune Sjögren’s Syndrome
Genomics & Informatics
autoantibodies
microRNAs
Sjögren’s syndrome
xerostomia
title MicroRNAs in Autoimmune Sjögren’s Syndrome
title_full MicroRNAs in Autoimmune Sjögren’s Syndrome
title_fullStr MicroRNAs in Autoimmune Sjögren’s Syndrome
title_full_unstemmed MicroRNAs in Autoimmune Sjögren’s Syndrome
title_short MicroRNAs in Autoimmune Sjögren’s Syndrome
title_sort micrornas in autoimmune sjogren s syndrome
topic autoantibodies
microRNAs
Sjögren’s syndrome
xerostomia
url http://genominfo.org/upload/pdf/gi-2018-16-4-e19.pdf
work_keys_str_mv AT seungheecha micrornasinautoimmunesjogrenssyndrome
AT mahmoudmona micrornasinautoimmunesjogrenssyndrome
AT kyungeunlee micrornasinautoimmunesjogrenssyndrome
AT dongheekim micrornasinautoimmunesjogrenssyndrome
AT kyudonghan micrornasinautoimmunesjogrenssyndrome